cheqfx
Advertisement · 728×90
‹ All stocks
EOLS

Evolus

EOLS · NASDAQ · Healthcare
$7.24
▼ $7.24 (-6.22%)
$7.24 $7.52 $7.80 $8.08 $7.24 Sep 26 Sep 30 Oct 04
Day range
$6.94 – $7.72
Year range
$3.86 – $9.31
Open
$7.72
Previous close
—
Market cap
$476.79M
Volume (24h)
$1.2M
Volume (52w)
$8.67M
Performance
7D
▼ -9.05%
1M
▼ -20.09%
3M
▲ 3.58%
6M
▲ 74.04%
1Y
▲ 16.03%
YTD
▲ 7.74%
3Y
▼ -16.97%
5Y
▼ -3.85%
All-time
▼ -37.04%
Key statistics
P/E ratio
-38.44
EPS (TTM)
$-0.19
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
65.9M
About Evolus

Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.

Visit website
Country: United States of America
More in Healthcare